2024 缉毒署大麻重新安排期限的裁决被推迟,导致市场下滑和库存下降。 2024 DEA cannabis rescheduling ruling delayed, causing market downturn and stock declines.
美国毒品执法局 (DEA) 推迟了对大麻重新安排的最终裁决,直到2024年总统选举之后,导致大麻行业的市场下滑以及诸如Curaleaf Holdings,Cresco Labs和Cansortium等大麻股票的大幅下跌. The U.S. Drug Enforcement Administration (DEA) delayed its final ruling on cannabis rescheduling until after the 2024 presidential election, causing a market downturn in the cannabis sector and significant declines in major cannabis stocks like Curaleaf Holdings, Cresco Labs, and Cansortium. 禁毒局为2024年12月设置了行政法法官听证会,增加了市场的不确定性。 The DEA set an Administrative Law Judge (ALJ) hearing for December 2024, increasing market uncertainty. 投资者应当为大麻股票价格可能下跌做好准备,并在作出投资决定之前考虑风险和回报。 Investors should be prepared for potential downturns in cannabis stock prices and consider risks and rewards before making investment decisions. 2024年选举的结果将严重影响大麻改期安排和该行业的未来。 The outcome of the 2024 election will significantly impact cannabis rescheduling and the future of the industry.